Association of 25‐Hydroxyvitamin D With Metabolic Dysfunction‐Associated Fatty Liver Disease: Results From NHANES 2017–2018
<b>Background:</b> The association of vitamin D with metabolic dysfunction-associated fatty liver disease (MAFLD) remained unclear. This study aimed to examine the relationships of total 25-hydroxyvitamin D [25(OH)D, the sum of 25(OH)D<sub>2</sub> and 25(OH)D<sub>3</sub>], 25(OH)D<sub>3</sub>, and epi-25(OH)D<sub>3</sub> with MAFLD. <b>Methods:</b> We used the National Health and Nutrition Examination Survey of the 2017-2018 cycle for our present analysis. Binary logistic regression analyses were conducted to explore the associations of total 25(OH)D, 25(OH)D<sub>3</sub>, and epi-25(OH)D<sub>3</sub> with MAFLD after adjusting for confounders. Interaction tests were conducted to compare the association between 25(OH)D and MAFLD in subgroups. <b>Results:</b> The final analysis included 4605 subjects. After adjustment for confounders, the odds of MAFLD decreased with increasing concentrations of total 25(OH)D (odds ratio [OR], 0.45; 95% confidence interval [CI], 0.29-0.68; <i>p</i> for trend < 0.001). Serum 25(OH)D<sub>3</sub> showed a strong inverse association with MAFLD (OR, 0.39; 95% CI, 0.25-0.59; <i>p</i> for trend < 0.001). In addition, participants with lower epi-25(OH)D<sub>3</sub> levels had a higher likelihood of MAFLD, as demonstrated in both quartile and continuous models (OR, 0.77; 95% CI, 0.60-0.99; <i>p</i>=0.041). After stratification by lipid status, inverse associations of total 25(OH)D and 25(OH)D<sub>3</sub> with MAFLD were found only in dyslipidemic participants (<i>p</i> for interaction < 0.001). A sex-specific interaction was also noted for 25(OH)D<sub>3</sub>, showing stronger effects in women than in men (<i>p</i>=0.036). <b>Conclusions:</b> Low serum total 25(OH)D, 25(OH)D<sub>3</sub>, and epi-25(OH)D<sub>3</sub> were significantly associated with a higher prevalence of MAFLD. These associations showed nonlinear patterns and were particularly evident among participants with dyslipidemia, with 25(OH)D<sub>3</sub> demonstrating stronger protective effects in women than in men. Given the cross-sectional design, causality cannot be inferred, and further prospective studies are required to confirm these findings.
Authors
- Junhe Wang
- Xiaojuan Rao
- Bo Huang (ORCID: https://orcid.org/0000-0002-3028-1945)
- Jingqiu Cui (ORCID: https://orcid.org/0000-0002-7568-3622)
- Ming Rong Liu (ORCID: https://orcid.org/0000-0003-2665-4072)
- Xinxin Zhang (ORCID: https://orcid.org/0000-0002-2344-2624)
- Shuo Li (ORCID: https://orcid.org/0000-0002-5184-3230)
- Tiekun Yan (ORCID: https://orcid.org/0000-0001-8211-0294)
Institutions
- Tianjin Medical University General Hospital (CN)
Publication Details
- Journal
- International Journal of Endocrinology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1155/ije/1368301
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China